FDA product approval
not established. No US therapeutic product approval is established by this curated source set; other countries and products may differ.
GH secretagogue · compound · checked 2026-10-09
CJC-1295 is a lab-made stand-in for GHRH, the signal that can raise growth hormone. Research-market listings next to this name are mostly “no DAC” / Mod GRF 1-29 vials at 5 mg, 8 mg, and 10 mg. This source set has no FDA-approved CJC-1295 drug. Names stay split.
Last checked Oct 9, 2026 by PepBear. Not medical advice.
DAC and no-DAC versions are different molecules. A Drug Affinity Complex changes how long it lasts. Seller titles that say “CJC-1295 no DAC (Mod GRF 1-29)” should be read as that sequence. They are not proven DAC-CJC-1295. The parent card and the no-DAC card stay linked so the names do not collapse.
Growth-hormone-releasing-hormone analogue; DAC and non-DAC naming must not be treated as interchangeable.
FDA product approval
not established. No US therapeutic product approval is established by this curated source set; other countries and products may differ.
Compounding
not established. Compounded products do not carry FDA product approval; legal eligibility is not established here.
Research
investigational. Limited human pharmacology data; no general wellness outcome established here.
Sport
prohibited. WADA S2 lists this GHRH analogue.
Early human papers on CJC-1295 with DAC (including PMID 16352683 and 17018654) measured growth hormone and IGF-1 after defined research doses. Those papers do not approve a wellness use. They do not certify today’s seller vials. FDA compounding-risk pages do not create a 503A monograph for this substance. Sport status is unverified on the catalog card. A missing listing is not permission. If your vial says Mod GRF 1-29 and the paper you printed used DAC-CJC-1295, the numbers on that printout belong to a different molecule.
We mark the cited papers as C. That is our label for how strong those papers are. It does not say the compound works.
The catalog does not record a single hour value. No verified formulation-specific human estimate in this source set; no guessed value is supplied.
Units charts on this page use 5 mg, 8 mg, and 10 mg because those masses appear on CJC-1295 no-DAC seller listings. The chart says so.
U-100 math for listed CJC-1295 (With DAC) sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.
These milligram sizes come from related CJC-1295 no-DAC vendor listings. The chart says so.
| Listed vial | 1 mL liquid | 2 mL liquid | 3 mL liquid |
|---|---|---|---|
| 5 mg | 50 | 25 | 16.7 |
| 8 mg | 80 | 40 | 26.7 |
| 10 mg | 100 | 50 | 33.3 |
People using PepBear often log: Existing clinician-directed records, symptoms and dated health measurements. Record missing data; trends do not demonstrate causation.
Both touch the GHRH path in different ways. Sermorelin had a former approved product (Geref) that was later pulled. CJC-1295 did not.
The parent CJC-1295 card has no standalone milligram listing in the vendor file. The no-DAC listings do. The chart says so instead of inventing a size.
A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.